BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 34156862)

  • 1. Lead Optimization of 3,5-Disubstituted-7-Azaindoles for the Treatment of Human African Trypanosomiasis.
    Klug DM; Mavrogiannaki EM; Forbes KC; Silva L; Diaz-Gonzalez R; Pérez-Moreno G; Ceballos-Pérez G; Garcia-Hernández R; Bosch-Navarrete C; Cordón-Obras C; Gómez-Liñán C; Saura A; Momper JD; Martinez-Martinez MS; Manzano P; Syed A; El-Sakkary N; Caffrey CR; Gamarro F; Ruiz-Perez LM; Gonzalez Pacanowska D; Ferrins L; Navarro M; Pollastri MP
    J Med Chem; 2021 Jul; 64(13):9404-9430. PubMed ID: 34156862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and Characterization of FTY720 for the Treatment of Human African Trypanosomiasis.
    Jones AJ; Kaiser M; Avery VM
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1859-61. PubMed ID: 26666915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of orally active anti-Trypanosoma agents.
    Salem FM; Martin WR; Zhao X; Adbus Sayeed SK; Ighneim S; Greene M; Mohamed E; Orahoske CM; Zhang W; Li B; Su B
    Bioorg Med Chem; 2024 Jun; 107():117751. PubMed ID: 38762979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a quinoline-based phenyl sulfone derivative as an antitrypanosomal agent.
    Zhang H; Collins J; Nyamwihura R; Ware S; Kaiser M; Ogungbe IV
    Bioorg Med Chem Lett; 2018 May; 28(9):1647-1651. PubMed ID: 29609908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tractable Quinolone Hydrazides Exhibiting Sub-Micromolar and Broad Spectrum Antitrypanosomal Activities.
    Chirwa KA; Francisco KR; Dube PS; Park H; Legoabe LJ; Teixeira TR; Caffrey CR; Beteck RM
    ChemMedChem; 2024 May; 19(9):e202300667. PubMed ID: 38326914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of human histone deacetylase with potent activity against the African trypanosome Trypanosoma brucei.
    Kelly JM; Taylor MC; Horn D; Loza E; Kalvinsh I; Björkling F
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1886-90. PubMed ID: 22326398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship of dibenzylideneacetone analogs against the neglected disease pathogen, Trypanosoma brucei.
    Francisco KR; Monti L; Yang W; Park H; Liu LJ; Watkins K; Amarasinghe DK; Nalli M; Roberto Polaquini C; Regasini LO; Eduardo Miller Crotti A; Silvestri R; Guidi Magalhães L; Caffrey CR
    Bioorg Med Chem Lett; 2023 Feb; 81():129123. PubMed ID: 36608774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-natural acetogenin analogues as potent Trypanosoma brucei inhibitors.
    Florence GJ; Fraser AL; Gould ER; King EF; Menzies SK; Morris JC; Tulloch LB; Smith TK
    ChemMedChem; 2014 Nov; 9(11):2548-56. PubMed ID: 25145275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of Aqueous Solubility of Lapatinib-Derived Analogues: Identification of a Quinolinimine Lead for Human African Trypanosomiasis Drug Development.
    Bachovchin KA; Sharma A; Bag S; Klug DM; Schneider KM; Singh B; Jalani HB; Buskes MJ; Mehta N; Tanghe S; Momper JD; Sciotti RJ; Rodriguez A; Mensa-Wilmot K; Pollastri MP; Ferrins L
    J Med Chem; 2019 Jan; 62(2):665-687. PubMed ID: 30565932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploration of DAPI analogues: Synthesis, antitrypanosomal activity, DNA binding and fluorescence properties.
    Farahat AA; Kumar A; Say M; Wenzler T; Brun R; Paul A; Wilson WD; Boykin DW
    Eur J Med Chem; 2017 Mar; 128():70-78. PubMed ID: 28152428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-Activity Relationships, Tolerability and Efficacy of Microtubule-Active 1,2,4-Triazolo[1,5-a]pyrimidines as Potential Candidates to Treat Human African Trypanosomiasis.
    Monti L; Liu LJ; Varricchio C; Lucero B; Alle T; Yang W; Bem-Shalom I; Gilson M; Brunden KR; Brancale A; Caffrey CR; Ballatore C
    ChemMedChem; 2023 Oct; 18(20):e202300193. PubMed ID: 37429821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of Bisnaphthalimidopropyl Derivatives against Trypanosoma brucei.
    Graça NA; Gaspar L; Costa DM; Loureiro I; Thoo-Lin PK; Ramos I; Roura M; Pruvost A; Pemberton IK; Loukil H; MacDougall J; Tavares J; Cordeiro-da-Silva A
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2532-6. PubMed ID: 26787703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of potent inhibitors of the Trypanosoma brucei methionyl-tRNA synthetase via high-throughput orthogonal screening.
    Pedró-Rosa L; Buckner FS; Ranade RM; Eberhart C; Madoux F; Gillespie JR; Koh CY; Brown S; Lohse J; Verlinde CL; Fan E; Bannister T; Scampavia L; Hol WG; Spicer T; Hodder P
    J Biomol Screen; 2015 Jan; 20(1):122-30. PubMed ID: 25163684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New organoruthenium complexes with bioactive thiosemicarbazones as co-ligands: potential anti-trypanosomal agents.
    Demoro B; Sarniguet C; Sánchez-Delgado R; Rossi M; Liebowitz D; Caruso F; Olea-Azar C; Moreno V; Medeiros A; Comini MA; Otero L; Gambino D
    Dalton Trans; 2012 Feb; 41(5):1534-43. PubMed ID: 22138896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multitask learning-driven identification of novel antitrypanosomal compounds.
    Lemos JM; Brito da Silva MF; Dos Santos Carvalho AM; Vicente Gil HP; Fiaia Costa VA; Andrade CH; Braga RC; Grellier P; Muratov EN; Charneau S; Moreira-Filho JT; Dourado Bastos IM; Neves BJ
    Future Med Chem; 2023 Aug; 15(16):1449-1467. PubMed ID: 37701989
    [No Abstract]   [Full Text] [Related]  

  • 16. Discovery of potent and selective inhibitors of Trypanosoma brucei ornithine decarboxylase.
    Smithson DC; Lee J; Shelat AA; Phillips MA; Guy RK
    J Biol Chem; 2010 May; 285(22):16771-81. PubMed ID: 20220141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluations of quinolone amides against African trypanosomiasis with improved solubility.
    Weinmann J; Kirchner L; Engstler M; Meinel L; Holzgrabe U
    Eur J Med Chem; 2023 Mar; 250():115176. PubMed ID: 36805945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of N-(2-aminoethyl)-N-benzyloxyphenyl benzamides: New potent Trypanosoma brucei inhibitors.
    Buchynskyy A; Gillespie JR; Hulverson MA; McQueen J; Creason SA; Ranade RM; Duster NA; Gelb MH; Buckner FS
    Bioorg Med Chem; 2017 Mar; 25(5):1571-1584. PubMed ID: 28187957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights in staging and chemotherapy of African trypanosomiasis and possible contribution of medicinal plants.
    Seke Etet PF; Mahomoodally MF
    ScientificWorldJournal; 2012; 2012():343652. PubMed ID: 22593674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of antitrypanosomal 1,2-dioxane derivatives based on a natural product scaffold.
    Holla H; Labaied M; Pham N; Jenkins ID; Stuart K; Quinn RJ
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4793-7. PubMed ID: 21757346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.